LIU, BIN,SHERBENOU, DANIEL W.,AFTAB, BLAKE T.,SU, YANG,BEHRENS, CHRISTOPHER R.
申请号：
CA3043277
公开号：
CA3043277A1
申请日:
2017.11.10
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
Disclosed herein are methods of treating a subject having a cancer characterized by a modification at biomarker 1q21, which comprises administering to the subject a therapeutically effective amount of an anti-CD46 antibody.
